ThronePR

TGV-inhalonix's New Drug To Help Patients With Resistant Fungal Lung Infections

Thu, May 11, 2017 13:55 ET

The New York drug development company says its Mul-1867 drug candidate shows high potential for treating cystic fibrosis and other severe lung infections.